High level FK778 | Mid level FK778 | Low level FK77 | MMF | |
---|---|---|---|---|
N = 87 | N = 92 | N = 92 | N = 93 | |
Age, mean (SD), y | 47.1 (11.8) | 48.2 (11.9) | 44.9 (12) | 46.8 (12.7) |
Male, % | 56.3 | 67.4 | 64.1 | 72 |
Caucasian, % | 96.6 | 94.6 | 96.7 | 95.7 |
Viral status, n (%): | ||||
HBV-positive | 5 (5.7) | 3 (3.3) | 6 (6.5) | 5 (5.4) |
CMV-positive a | 58 (66.7) | 57 (62) | 55 (59.8) | 65 (69.9) |
HCV-positive a | 3 (3.4) | 6 (6.5) | 3 (3.3) | 3 (3.2) |
EBV-positive a | 47 (54) | 45 (48.9) | 48 (52.2) | 53 (57) |
CMV status: donor +/recipient-, n (%) | 14 (18.2) | 9 (11) | 14 (16.9) | 11 (12.6) |
First renal transplant, n (%) | 82 (94.3) | 85 (92.4) | 82 (89.1) | 87 (93.5) |
Deceased donor organ, n (%) | 82 (94.3) | 90 (97.8) | 85 (92.4) | 85 (91.4) |
Cold ischemia time, | 15.9 (6.5) | 17.2 (6.3) | 16.5 (6.7) | 17.1 (7.2) |
mean (SD), h | ||||
Donor age, mean (SD), y | 47.2 (11.2) | 44.7 (13.7) | 42.9 (13) | 43.5 (13.7) |
Male organ donor, n (%) | 42 (48.3) | 57 (62) | 58 (63) | 61 (65.6) |
Mean total HLA mismatch | 2.7 | 2.8 | 2.5 | 2.6 |